Licensing as a Commercialisation Strategy for Biotechnology Firms
This paper reports on a study of the licensing strategies of new firms in the biotechnology industry in Germany and compares data with previous research in the United States.
Michael DOWLING Roland HELM
Innovation and Technology Management, University of Regensburg, 93040 Regensburg, Germany Marketing and Business Administration,Friedrich-Schiller-University Jena, 07743 Jena, Germany
国际会议
The Fifth InternationalSymposium on Management of Technology(ISMOT07)(第五届技术与创新管理国际研讨会)
杭州
英文
1158-1161
2007-06-01(万方平台首次上网日期,不代表论文的发表时间)